16th Annual Outsourcing in Clinical Trials East Coast 2025

Discover effective strategies for outsourcing clinical trial operations to ensure trials run smoothly and within budget

20 - 21

May

2025
  • Valley Forge Casino Resort, King of Prussia, USA
  • Complimentary
  • Why attend?
  • Agenda
  • Advisory Board
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Media Centre
  • Why partner?
  • Resources
  • Contact Us
close

Why attend?

WHAT TO EXPECT FOR 2025?

450+

Attendees

70+

Exhibitors

30+

Speakers

450+

Attendees

70+

Exhibitors

30+

Speakers

See What It's All About

Agenda

  • 20 May 2025
  • 21 May 2025
Expand All

Streams

Stream one

Clinical Operations and Outsourcing

Stream two

Clinical Technology and Innovation

12:45 PM

Innovations in patient recruitment, powered by AI

  • Understand how AI is revolutionizing how content is rated and qualified by enhancing precision and accelerating the speed of communication
  • Experience a real-life AI application used to optimize patient recruitment materials
  • Gain insights into future trends and opportunities in AI-powered translation for the life sciences sector, including regulatory compliance for labeling

Speakers

Stephane Millet
Director, Clinical and Patient Engagement Solutions, Acolad Life Sciences
Kathleen O’Brien
Head of Sales, Acolad Life Sciences

10:30 AM

Morning refreshments and networking break

Streams

Stream one

Clinical Technology and Innovation

9:45 AM

TECHNOLOGY SPOTLIGHT: Establishing data governance as a best practice in your clinical eco-system

Join for an insightful session on the world of data governance and security for the modern biotech. In this session, we will provide invaluable insights and practical strategies to help you optimize your clinical trial operations while ensuring the security of your sensitive data. Gain insight into areas such as mastering your data, the role of data governance in life sciences, and solving challenges in implementing data governance within your organization.

Speakers

Cat Hall
Head of GXP Assurance, Egnyte

Streams

Stream one

Clinical Operations and Outsourcing

Stream two

Clinical Technology and Innovation

11 AM

PANEL: Innovation and technology in clinical trials: exploring emerging and upcoming trends

• Is decentralization of clinical trials still relevant in 2025?
• Incorporating remote monitoring tools such as wearables into clinical trials
• An overview of new tools and solutions available on the market
• The growth of GenAI: when will this become widely used in clinical research?
• Balancing new techno

MODERATOR:
Rich Polgar, Managing Director, Danforth Advisors

PANELLISTS:
Ashlyn Jose, Director, Clinical Operations, Kyowa Kirin, Inc
Ram Raju, Senior Vice President and Community Health Investment Officer, Northwell Health
Kristen Olszyk, Vice President, Clinical Operations, Neuraptive Therapeutics
Stefanie Kuhner, Head of Clinical Technology, Innovation and Patient Recruitment, Bristol Myers
Squibb

Speakers

Rich Polgar
Director Global Procurement, Bristol-Myers Squibb
Ashlyn Jose
Director, Clinical Operations, Kyowa Kirin, Inc
Ram Raju
Senior Vice President and Community Health Investment Officer, Northwell Health
Kristen Olszyk
Senior Director, Clinical Scientist, Neuraptive Therapeutics
STEFANIE KUHNER
Global Head Of Clinical Technology, Innovation & Patient Recruitment – Strategic Sourcing & Procurement, Bristol Myers Squibb

11:30 AM

Community is the new site: redefining trial footprints to expand access

As the clinical research industry pushes toward innovative solutions to increase inclusivity and access, it’s time to look beyond traditional site-based trial models and digital platforms. Expanding access isn’t just about technology-centered solutions – it’s about rethinking where and how trials happen. This session explores how community-based research models, including mobile research sites, mobile clinicians, and flexible visit options, are redefining what it means to bring research to patients. This session will explore how building trust and presence in local communities leads to better enrollment, stronger retention, and more representation data.

Speakers

Nancy Lizzul
Director, Site Operations, EmVenio Research

12 PM

CASE STUDY: Getting a new site up and running: challenges, opportunities and lessons learned

  • Top tips for working with and supporting naïve physicians in order to ensure their success
  • The importance of new study sites as a way of meeting FDA diversity requirements
  • Lessons learned for the future: what should you consider when working with naïve doctors?

Carrie Lewis, Executive Director, Clinical Program
Optimization, Endo
Suzy Montanye, Site Relationship Manager, Endo

Speakers

Carrie Lewis
Executive Director, Clinical Program Optimization, Endo Pharmaceuticals
Suzy Montanye
Site Relationship Manager, Endo Pharmaceuticals

12:30 PM

Achieving submission excellence with Certara’s regulatory operations solutions

  • Defining the full lifecycle of clinical and regulatory documents
  • Identifying practical actions authors can take to facilitate compliance with electronic regulatory submission requirements
  • Describing how technology tools are used to ensure efficient workflows and regulatory compliance

Speakers

Evan Richardson
Senior Director, Regulatory Operations and Clinical Disclosure, Certara

1 PM

Lunch and networking

2 PM

PANEL: AI and machine learning in clinical trials: where are we in 2025?

  • Opportunities for incorporating AI into clinical research: where should the industry be focusing?
  • Why has pharma been relatively slow to utilize AI in clinical research?
  • Understanding limitations of GenAI: what do you need to be wary of?
  • Real case studies on AI in the clinical trial industry: where has there been progress and success?
  • What does the future hold for AI in clinical trials?

MODERATOR:
Judyth Zahora, Senior Director, Clinical QA and Process Improvement, Zentalis Pharmaceuticals

PANELLISTS:
Rosanne Petros, Associate Director, Clinical Research, Merck Research Laboratories
Bryan Clayton, Clinical Systems Consultant, Alnylam Pharmaceuticals
Paresh Patel, Head of Global Clinical Intelligence, Otsuka

Speakers

Rosanne Petros
PMP, Associate Director, Clinical Research, Merck Research Laboratories
Bryan Clayton
Chief Commercial Officer, Endpoint Clinical
Paresh Patel
Head Of Global Clinical Intelligence, Otsuka
Judyth Zahora
Senior Director, Global Quality Systems and Process Improvement, Agenus

2:30 PM

Expanding the patient universe: transforming clinical trials through inclusive, data-driven design

  • Discover how integrating health equity & SDoH data improves patient representation and accessibility in clinical trials
  • Learn how H1 supports sponsors in designing inclusive, patient-centric trials to meet diversity action plan requirements and feasibility benchmarks
  • Explore real-world applications of inclusive research strategies that have successfully expanded patient diversity and engagement

Speakers

Chris Riley
Ph.D, Senior Product Manager, H1 Clinical

3 PM

Topic TBC

Dr Thomas Hopkins, Chief Medical Officer, AccuVein

3:30 PM

Afternoon refreshments, networking

4 PM

Health literacy in clinical trials: ensuring information is clear and accessible to patients

  • Technology and innovation for addressing health literacy and how information is presented to patients
  • Integrating health literacy principles into all phases of clinical research
  • How low health literacy can

Speakers

Lucas Goren
Senior Project Manager, CISCRP

4:30 PM

CASE STUDY: Practical aspects of running a clinical trial when repurposing an existing drug

  • Benefits of repurposing: how this can save time and money, and reduce risk to patients
  • How to effectively utilize real world data when repurposing existing drugs
  • Speeding up regulatory approval for a repurposed drug: how to navigate FDA guidelines

Speakers

John Seman
Chief Executive Officer, REVITALE Pharma

7:30 AM

Registration & Refreshments

8:30 AM

Chairperson’s opening remarks

Speakers

Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals

8:45 AM

Evolving sourcing needs and models in clinical R&D

Clinical R&D outsourcing needs and models have evolved over the last few years. Many biopharma companies are transitioning to a function-driven sourcing model where we can have a set of fit-for-purpose preferred suppliers to bring in flexibility and agility. Challenges in sourcing needs, pros and cons of different sourcing models will be discussed.

Speakers

Mohan Bangalore
PhD, Director, Global R&D Procurement and Supplier Management, Organon

9:15 AM

Smarter, faster, autonomous: the future of clinical data management with generative and agentic AI

  • How Generative AI can streamline clinical data review, enhance efficiency, and reduce operational burden
  • Agentic AI’s potential to elevate data management from task-based automation to intelligent, autonomous systems
  • Real-world applications demonstrating the impact of AI-powered agents in clinical trial oversight
  • What’s next in AI evolution and how to prepare your data management processes for scalable change

Speakers

Prasanna Rao
Chief Product and Innovation Officer, Saama

9:45 AM

PANEL: Diversity in clinical trials: how to ensure your clinical study has diverse representation

  • Addressing historical issues with trial recruitment in certain populations in order to ensure diversity
  • Community outreach as a method to reduce distrust around clinical trial participation
  • Sourcing new sites in communities with high numbers of under-represented populations
  • Language and translation: how to ensure your trial materials are accessible to non English speaking participants

Speakers

Ram Raju
Senior Vice President and Community Health Investment Officer, Northwell Health
Patrick Floody
Executive Director, Global Clinical Trial Services
Lucas Goren
Senior Project Manager, CISCRP
Kathleen Cohen
Vice President, Clinical Development, Marinus Pharmaceuticals

10:30 AM

Morning refreshments and networking break

11 AM

Innovative approaches to measure your performance and identify areas for improvement in supplier relationships

  • KPIs in clinical research: what should you be measuring to determine your performance?
  • Working collaboratively with your CROs and vendors throughout your clinical trial: where are you falling short?
  • Tools and technology available to facilitate processes around performance measurement

Speakers

Jim Mordaga
MBA, MA, Senior Director, Medical Platforms and Intelligence, Novartis
Amanda Murphy
Senior Director, Data Intelligence & Solutions,
GlobalData

11:30 AM

Reserved for ICON Plc

12 PM

PANEL: Best practice in supplier relationship management: managing evolving needs to foster positive collaboration

• Priorities and considerations when working with vendors and external suppliers
• Cultivating collaborative relationships with vendors and CROs
• Managing procurement and outsourcing during an integration of two companies
• Developing a plan for effective supplier relationship management to ensure your trial runs smoothly

MODERATOR:
John Seman, Chief Executive Officer, Revitale Pharma

PANELLISTS:
Albert A Siha, Group Lead Director, Oncology, Internal Medicine, and Inflammation & Immunology, Pfizer Nupur Modi Murali, Director, Clinical Operations, Bausch Health Kathleen Cohen, Senior Vice President, Clinical Development Operations, Avalo Therapeutics Susan Neal, Senior Director, Clinical Operations, Novavax

Speakers

John Seman
Chief Executive Officer, REVITALE Pharma
Albert A Siha
Director, Oncology Unit Management Office, Procurement and Supplier Relationship Manager, Pfizer
Nupur Modi Murali
Director, Clinical Operations, Bausch Health
Kathleen Cohen
Vice President, Clinical Development, Marinus Pharmaceuticals
Susan Neal
Director, Clinical Operations, Novavax

12:30 PM

Trump Administration effect on healthcare through the lens of a former regulator

  • Healthcare themes in a Trump Administration
  • Update on key priorities and opportunities
  • Short and long term effects of staffing and budget cuts

Speakers

Patrick Ronan
Operating Partner, ArchiMed and Board of Directors, Symbio Research

1 PM

Lunch and networking

2 PM

Marriage counseling: how two nurses from both the hospital and industry side see us resolving the site v sponsor chasm

  • What sites really want and need, and why they don’t understand sponsors
  • What sponsors really want and need, and why they don’t understand sites
  • Areas of common ground
  • How sites and sponsors can reconcile and work together to find success

Speakers

Linda Miller
Senior Clinical Operations Lead, Incyte
Todd Nicklas
Clinical Trial Manager, Incyte

2:30 PM

Built different: how a BioA-rooted central lab delivers precision in a dynamic clinical landscape

Most central labs are built to process samples. Ours was built to understand them. Evolving from a world-class bioanalytical backbone, Frontage Central Lab brings scientific depth, quality rigor, and operational discipline to every protocol, amendment, and shipment. This talk unpacks how our BioA heritage uniquely equips us to manage complex sample logistics, adapt to protocol deviations, and align with today's complex and evolving clinical trials!

Speakers

Dr Nan Zhang
Senior Vice President, Central Lab, Biomarker and Biologics Services, Frontage Laboratories

3 PM

PANEL: Handling clinical trial finances: tips for managing funding, investment and budgets

• Ensuring your trial is cost-conscious and efficient without compromising on quality or on patient care
• Forecasting and budgeting in order to accurately predict costs and minimize unforeseen expenses
• Keeping your clinical budget on track
• Negotiating prices and contracts in order to ensure maximum benefit without going over budget

Speakers

Rich Polgar
Director Global Procurement, Bristol-Myers Squibb
Lauren Colfer
Former Vice President, Clinical Operations at Aceragen Pharmaceuticals
Amber Knight
Associate Director, R&D Procurement, Organon
Rick O’Hara
Director, R&D Business Operations, OncoC4

3:30 PM

Afternoon refreshments, networking

3:50 PM

EXHIBITION APPLE PRIZE DRAW

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

4 PM

What does patient centricity mean in an outsourcing context?

  • Ensuring patients are at the forefront of conversations with CROs and vendors
  • Considering vendor selection processes with the patient in mind: what does this look like?
  • Working closely with patient advocacy groups alongside CROs and vendors to deliver a patientcentric clinical trial

Speakers

Amber Knight
Associate Director, R&D Procurement, Organon

4:30 PM

Reserved for Harvest Integrated Research Organization (HiRO)

5 PM

KEYNOTE PRESENTATION AND WORKSHOP: Applying AI to our clinical operations challenges

  • What’s stopping us from using AI?
  • How to overcome barriers to AI: creative starter ideas
  • AI case studies, stories and key takeaways

Speakers

Dan Seewald
Co-Founder and COO, LiviWell and Founder and CEO, Deliberate Innovation

5:45 PM

Chairperson’s closing remarks

Speakers

Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals

5:50 PM

NETWORKING DRINKS RECEPTION AND END OF DAY 1

Streams

Stream one

Clinical Operations and Outsourcing

Stream two

Clinical Technology and Innovation

9 AM

Medically underserved populations and the impact on rare disease clinical trials

  • Insights on the differences between represented and underrepresents populations on their barriers to care
  • Challenges and nuances of rare disease patients’ journey to receive a diagnosis
  • Mental health and well-being: the emotional toll rare diseases take on patients and caregivers
  • Exploring overall experiences individuals have had within the healthcare system: strengths and areas for improvement

Harsha K. Rajasimha, MS, Ph.D, Founder and Executive Chairman, Indo US Organization for Rare Diseases

Speakers

Harsha K. Rajasimha
MS, Ph.D, Founder and Executive Chairman, Indo US Organization for Rare Diseases

9:30 AM

The innovation mandate: how to thrive in a rapidly evolving world of data and analytics

  • The current landscape of technology and analytics including some of the notable recent advances
  • How new technologies (eg GenAI and Predictive Modeling) can change the life sciences industry
  • What we need to do today to see tangible value and be ready to adapt to future developments

Speakers

Walter Boyle
Executive Director, Biostatistics and Programming

10 AM

A YEAR ON UPDATE: Critical to quality factors Part 2: operationalization of the concept in a pilot study

Jehan Poco, Associate Director, BDM Planning and Functional Excellence, Biostatistics and Data Management, Daiichi Sankyo, Inc
Kevin Douglass, Associate Director, RBQM Center of Excellence, Biostatistics and Data Management, Daiichi Sankyo, Inc

Speakers

Jehan Poco
Associate Director, BDM Planning and Functional Excellence, Biostatistics & Data Management, Daiichi Sankyo, Inc
Kevin Douglass
Associate Director, RBQM Center of Excellence, Global Clinical Operations, Daiichi Sankyo, Inc

10:30 AM

Morning Refreshments & Networking

11:15 AM

PANEL: Optimizing remote data capture: new trends and technology in data acquisition

  • Incorporating innovative products and tools into your clinical trial for remote data capture
  • FDA regulatory guidance around data acquisition and collecting data in remote settings
  • Easing burden on patients through remote data collection: how to utilize these tools effectively
  • How new tools such as eCOA solve patient issues

MODERATOR:
Terry Katz, Senior Director, Biostatistics and Data
Management Planning and Functional Excellence, Daiichi
Sankyo, Inc
PANELLISTS:
Robert Besthof, Chief Operating Officer, RiboNova
TJ Sharpe, Patient Advocate
Further panellists to be confirmed

Speakers

Terry Katz
Senior Director, Biostatistics, Data Management Planning, Functional Excellence, Daiichi Sankyo
Robert Besthof
Chief Operating Officer, RiboNova

11:45 AM

Leveraging technology for seamless collaboration

This session will include demonstrations and case study data illustrating how novel, effective technology-driven strategies can remove workflow friction and improve project delivery across several clinical workflows that are complex and dynamic, requiring multi-stakeholder inputs and timely, complex data exchanges. In this session, you will learn how to optimize your processes for patient eligibility review, remote monitoring and more – all in one collaboration platform!

Speakers

Jamie Russo
Head of Product, AG Mednet

8 AM

Registration and Refreshments

8:50 AM

Chairperson’s opening remarks

Speakers

Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals

9 AM

PANEL: Ensuring your FSP model is a success: what do you need to know?

• Working closely with FSP vendors: how much oversight do you need?
• Benefits and challenges of moving to an FSP outsourcing model
• Comparing vendor management strategies between pharma and biotechs: do you need a different
approach?
• Why is FSP becoming a popular outsourcing model: what benefits can this offer sponsors?

 

MODERATOR:
Rich Polgar, Managing Director, Danforth Advisors

PANELLISTS:
Melanie Goodwin, Director, Clinical Outsourcing,
Immunocore
Russell Bland, Director, Clinical Outsourcing and
Innovation, Jazz Pharmaceuticals
Terry Katz, Senior Director, Biostatistics and Data
Management Planning and Functional Excellence, Daiichi
Sankyo, Inc

Speakers

Rich Polgar
Director Global Procurement, Bristol-Myers Squibb
Melanie Goodwin
Director, Clinical Outsourcing, Immunocore
Russell Bland
Director, Clinical Outsourcing and Innovation, Jazz Pharmaceuticals
Terry Katz
Senior Director, Biostatistics, Data Management Planning, Functional Excellence, Daiichi Sankyo

9:30 AM

What do you mean you need equipment? Demystifying the complexities of the equipment supply chain

  • Explore the critical role of equipment in enabling clinical trial success, from ensuring compliance to supporting protocol-specific needs
  • Understand key challenges in the equipment supply chain, including global logistics, maintenance, and vendor management
  • Discover practical solutions such as centralized planning, global harmonization, and the use of technology to optimize supply chain performance
  • Learn from real-world examples that illustrate how proactive equipment management can save time, reduce costs, and ensure continuity across trials

Speakers

Jonathan Raven
Chief Commercial Officer, Emsere Bryan Dunlap, Business Development Manager, North America, Emsere

10 AM

PANEL: Preparing for an FDA inspection: common pitfalls and ensuring your study is ready for approval

  • Reviewing last year’s FDA feedback on audits: what were the main reasons for failure?
  • Tips and tricks to ensure you are ready for inspection
  • Simplifying processes in order to prepare for an FDA inspection

Speakers

Judyth Zahora
Senior Director, Global Quality Systems and Process Improvement, Agenus
Samantha Beddows
Director, Data Management, Oncology, AstraZeneca

10:30 AM

Morning refreshments and networking

11:15 AM

Choosing CRO and vendor partners as a small biotech sponsor: priorities and key considerations

  • • How vital is knowledge of therapeutic area in CRO selection?
    • As a small biotech, is it beneficial to work with a smaller CRO or a large global CRO?
    • Ensuring your CRO and vendor partners prioritize your study

11:45 AM

Driving success: strategies for optimal site support

  • Understand how the increasing complexity of clinical trials, higher competition, and site staff turnover are driving the need for more engaged site support
  • Learn how (CROs) provide crucial support through improved communication and tailored site resources
  • Explore how sponsors can enhance site performance through clear expectations and data-driven collaboration
  • Discover strategies for streamlining processes and improving site engagement to drive trial success

Speakers

Eleanor Miller
Clinical Trial Liaison, PSI CRO

12:15 PM

The state of the biopharmaceutical industry in 2025

  • Key themes and technology advancements in biopharma
  • Spotlight on clinical trial technologies for drug development
  • Leveraging data to predict the outlook for 2025 clinical trial outsourcing
  • Trends, key players, opportunities and threat in biopharma
  • What the latest investment trends show for small to medium biotechs

Speakers

Amanda Murphy
Senior Director, Data Intelligence & Solutions,
GlobalData

12:45 PM

Lunch and Networking

1:45 PM

KEYNOTE PRESENTATION: Establishing a Center of Excellence for gene therapy and vaccines

Speakers

Gurdyal Kalsi
Chief Medical Officer, Asklepion Pharmaceuticals

2:15 PM

PANEL: Navigating the outsourcing landscape for emerging therapy areas

  • An overview of emerging therapy areas including women’s health, cell and gene therapy and rare diseases
  • Designing a successful patient recruitment strategy: common challenges and how to overcome these
  • Vendor sourcing: key considerations in vendor selection
  • How important is therapeutic area knowledge when choosing CROs and partners?

MODERATOR:
Judyth Zahora, Senior Director, Clinical QA and Process Improvement, Zentalis Pharmaceuticals
PANELLISTS:
Gurdyal Kalsi, Chief Medical Officer, Asklepion Pharmaceuticals
Mohan Bangalore, PhD, Director, Global R&D Procurement and Supplier Management, Organon
Harsha K. Rajasimha, MS, Ph.D, Founder and Executive Chairman, Indo US Organization for Rare Diseases
Priya Marreddy, Vice President, Clinical Operations, OnCusp Therapeutics

Speakers

Judyth Zahora
Senior Director, Global Quality Systems and Process Improvement, Agenus
Gurdyal Kalsi
Chief Medical Officer, Asklepion Pharmaceuticals
Mohan Bangalore
PhD, Director, Global R&D Procurement and Supplier Management, Organon
Harsha K. Rajasimha
MS, Ph.D, Founder and Executive Chairman, Indo US Organization for Rare Diseases
Priya Marreddy
Vice President, Clinical Operations, OnCusp Therapeutics

2:45 PM

Afternoon refreshments and networking

3:05 PM

EXHIBITION APPLE PRIZE DRAW

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss 0ut!

3:15 PM

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

During the roundtable discussion session, the conference hall will be divided into four ‘zones’. Delegates can choose which zone they would like to join. Each zone will focus on a different challenge within clinical operations.

ROUNDTABLE 1: Developing a successful Diversity Action Plan for your clinical trial
ROUNDTABLE 2: Creating an AI strategy to support clinical research
ROUNDTABLE 3: Key considerations when selecting a CRO
ROUNDTABLE 4: Working with advocacy groups to keep the patient voice at the heart of your trial

 

4:15 PM

End of conference

END OF CONFERENCE – SEE YOU NEXT YEAR!

Speakers

Select a speaker to learn more

Back
Dr Thomas Hopkins
Chief Medical Officer, AccuVein
Next speaker
Back
Amber Knight
Associate Director, R&D Procurement, Organon

Session Details:

What does patient centricity mean in an outsourcing context?

2025-05-20, 4:00 PM

Session Details:

PANEL: Handling clinical trial finances: tips for managing funding, investment and budgets

2025-05-20, 3:00 PM

View In Agenda
Next speaker
Back
Bryan Clayton
Chief Commercial Officer, Endpoint Clinical

Bryan Clayton is a seasoned global commercial leader with experience across multiple functions including sales and marketing, operations, and software product design. For over 20 years, he has effectively managed cross-functional teams, created new technology solutions, managed contract negotiations, and driven revenue growth for top life sciences technology and solutions providers. Bryan is a sought-after speaker, writer and contributor to industry events and publications, and possesses a range of skills well-suited to boost commercial success and revenue growth.

Bryan joined endpoint Clinical in 2023 as Chief Commercial Officer to lead commercial strategy and business development operations, and to further strengthen endpoint’s expertise in providing agile, patient centric IRT solutions. In his spare time, Bryan coaching and playing baseball.

Session Details:

PANEL: AI and machine learning in clinical trials: where are we in 2025?

2025-05-20, 2:00 PM

View In Agenda
Next speaker
Back
Gurdyal Kalsi
Chief Medical Officer, Asklepion Pharmaceuticals

Session Details:

KEYNOTE PRESENTATION: Establishing a Center of Excellence for gene therapy and vaccines

2025-05-21, 1:45 PM

Session Details:

PANEL: Navigating the outsourcing landscape for emerging therapy areas

2025-05-21, 2:15 PM

View In Agenda
Next speaker
Back
Samantha Beddows
Director, Data Management, Oncology, AstraZeneca

Session Details:

PANEL: Preparing for an FDA inspection: common pitfalls and ensuring your study is ready for approval

2025-05-21, 10:00 AM

View In Agenda
Next speaker
Back
Kathleen Cohen
Vice President, Clinical Development, Marinus Pharmaceuticals

Kathleen Frenia Cohen is Vice President and Head of Clinical Development Operations at Marinus Pharmaceuticals.  Prior to joining Marinus, she spent 20+ years at PRA Health Sciences in a variety of project management and operational oversite roles. Kathleen graduated from the University of the Science in Philadelphia with a PharmD and completed a post-doctoral fellowship in Pharmacoeconomics and Outcomes Research from Rutgers College of Pharmacy. Kathleen resides in Media, PA.

Session Details:

PANEL: Best practice in supplier relationship management: managing evolving needs to foster positive collaboration

2025-05-20, 12:00 PM

Session Details:

PANEL: Diversity in clinical trials: how to ensure your clinical study has diverse representation

2025-05-20, 9:45 AM

View In Agenda
Next speaker
Back
Nupur Modi Murali
Director, Clinical Operations, Bausch Health

Session Details:

PANEL: Best practice in supplier relationship management: managing evolving needs to foster positive collaboration

2025-05-20, 12:00 PM

View In Agenda
Next speaker
Back
Stefanie Kuhner
Global Head Of Clinical Technology, Innovation & Patient Recruitment – Strategic Sourcing & Procurement, Bristol Myers Squibb
Next speaker
Back
Evan Richardson
Senior Director, Regulatory Operations and Clinical Disclosure, Certara

Session Details:

Achieving submission excellence with Certara’s regulatory operations solutions

2025-05-20, 12:30 PM

View In Agenda
Next speaker
Back
Lucas Goren
Senior Project Manager, CISCRP

Session Details:

PANEL: Diversity in clinical trials: how to ensure your clinical study has diverse representation

2025-05-20, 9:45 AM

Session Details:

Health literacy in clinical trials: ensuring information is clear and accessible to patients

2025-05-20, 4:00 PM

View In Agenda
Next speaker
Back
Walter Boyle
Executive Director, Biostatistics and Programming

Session Details:

The innovation mandate: how to thrive in a rapidly evolving world of data and analytics

2025-05-21, 9:30 AM

View In Agenda
Next speaker
Back
Terry Katz
Senior Director, Biostatistics, Data Management Planning, Functional Excellence, Daiichi Sankyo

Terry Katz is Senior Director of Biostatistics and Data Management Planning and Functional Excellence at Daiichi Sankyo. Previously he was Head of Global Data Management and Statistics at Merck Animal Health, Head of Biometrics at ImClone Systems, Senior Manager of Analysis & Reporting for PRA International, and a Statistician at Schering-Plough. He holds Accreditation as a Professional Statistician and Certifications as a Quality Engineer and a Six Sigma Green Belt. He is Chair of DIA's GCP-QA Community; formerly he was a Core Committee member for NJ CDISC User Group and Chair of the Statistical Taskforce for the Animal Health Institute. Terry also completed a 3-month Fellowship in Kenya to improve capacity and capability for the local hospitals to run oncology clinical trials.

Session Details:

PANEL: Ensuring your FSP model is a success: what do you need to know?

2025-05-21, 9:00 AM

Session Details:

PANEL: Optimizing remote data capture: new trends and technology in data acquisition

2025-05-21, 11:15 AM

View In Agenda
Next speaker
Back
Kevin Douglass
Associate Director, RBQM Center of Excellence, Global Clinical Operations, Daiichi Sankyo, Inc

Kevin Douglass, Associate Director, RBQM Center of Excellence, Biostatistics & Data Management (BDM), Daiichi Sankyo, Inc.

 

Kevin is an Associate Director in the Risk-Based Quality Management Center of Excellence (RBQM COE) at Daiichi-Sankyo.  The RBQM COE partners within BDM, with cross-functional stakeholders, and CRO partners to optimize RBQM processes and tools.  The RBQM COE has central (e.g., as process owners developing and delivering tools and training) and Program/Study-level responsibilities (providing guidance to study teams).

 

Kevin has 40+ years of industry experience working for numerous companies in various positions (Data Management, Quality & Compliance, Operational Excellence/Change Management, and RBQM).  He received a BS in Biology from Ursinus College, an MS in Biology from Villanova University, and is certified in Lean Six Sigma and multiple Change Management methodologies.

 

Kevin can be contacted at kdouglass@dsi.com.

Session Details:

A YEAR ON UPDATE: Critical to quality factors Part 2: operationalization of the concept in a pilot study

2025-05-21, 10:00 AM

View In Agenda
Next speaker
Back
Jehan Poco
Associate Director, BDM Planning and Functional Excellence, Biostatistics & Data Management, Daiichi Sankyo, Inc

Jehan, Associate Director, Functional Excellence, Biostatistics & Data Management (BDM), Daiichi Sankyo, Inc.

 

Jehan is an Associate Director in the Biostatistics & Data Management Functional Excellence at Daiichi-Sankyo.  In this role, Jehan partners with BDM and R&D teams on functional initiatives, system roll outs, and committee as well as supporting key partners like the RBQM COE as a member.

 

Jehan has 18+ years of industry experience working for numerous companies in various positions (TMF, Clinical Monitoring, Quality & Compliance, Operational Excellence/Change Management, Metrics/Benchmarking and RBQM).  He received a BA in Cell Biology & Neuroscience from Rutgers College, an MBS in Biomedical Science from the University of Medicine and Dentistry NJ (UMDNJ), and is certified Auditing and Change Management methodologies.

 

Jehan can be contacted at jpoco@dsi.com

Session Details:

A YEAR ON UPDATE: Critical to quality factors Part 2: operationalization of the concept in a pilot study

2025-05-21, 10:00 AM

View In Agenda
Next speaker
Back
Rich Polgar
Director Global Procurement, Bristol-Myers Squibb

NULL

Session Details:

PANEL: Handling clinical trial finances: tips for managing funding, investment and budgets

2025-05-20, 3:00 PM

Session Details:

PANEL: Ensuring your FSP model is a success: what do you need to know?

2025-05-21, 9:00 AM

Session Details:

PANEL: Innovation and technology in clinical trials: exploring emerging and upcoming trends

2025-05-20, 11:00 AM

View In Agenda
Next speaker
Back
Dan Seewald
Co-Founder and COO, LiviWell and Founder and CEO, Deliberate Innovation

Session Details:

KEYNOTE PRESENTATION AND WORKSHOP: Applying AI to our clinical operations challenges

2025-05-20, 5:00 PM

View In Agenda
Next speaker
Back
Jonathan Raven
Chief Commercial Officer, Emsere Bryan Dunlap, Business Development Manager, North America, Emsere

Session Details:

What do you mean you need equipment? Demystifying the complexities of the equipment supply chain

2025-05-21, 9:30 AM

View In Agenda
Next speaker
Back
Bryan Dunlap
Business Develop Manager, North America, Emsere

Bryan brings over nine years of experience in clinical trial support, having held diverse roles at Emsere in logistics, equipment preparation and testing, project management, and business development. His multifaceted career has provided him with a comprehensive understanding of the clinical trial landscape, including the numerous factors and touchpoints that can influence trial success. Bryan’s cross-departmental expertise enables him to identify potential challenges, anticipate real-world implications of decisions, and provide actionable insights to ensure smoother trial operations.

Next speaker
Back
Nancy Lizzul
Director, Site Operations, EmVenio Research

Session Details:

Community is the new site: redefining trial footprints to expand access

2025-05-20, 11:30 AM

View In Agenda
Next speaker
Back
Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals

In her over 25 years of experience, Rosalie “Rosie” Filling has transformed R&D operations in every company she has worked for, developing clear-cut strategies to help advance clinical trials with high-quality operational execution and scientific excellence.

 

Rosie is the Vice President, Senior Global Head R&D Operations Endo International plc. She is part of the global R&D leadership team and is charged with the coordination and implementation of clinical development strategies for the company’s research and development. She provides strategic direction and oversight of the R&D Operations team, which includes clinical operations, data management, biostatistics, medical writing, clinical supplies, trial master file/inspection readiness and business operations. This integrated team handles the execution of all aspects related to Endo’s clinical trials. Endo has active research and development programs in men’s health, orthopedics, and endocrinology. Beyond these therapeutic areas, the company also has focused development in the areas of sterile injectables and complex generic products.

 

Rosie’s main focus at all times is on the end users—the patients. Bringing new and, at times, life-saving medications to patients drives Rosie’s sense of purpose.

 

Rosie joined Endo from Lupin Pharmaceuticals in Blue Bell, PA where she was Senior Director, Head of Clinical Operations, and built the clinical operations organization to support the US and Global R&D Organization. Prior to Lupin, Rosie spent nearly five years at Teva in Frazer, PA where she was the US site head of Clinical Operations and was responsible for the successful delivery of Inhalation, Women’s Health, and Cardiovascular clinical trials. Earlier in her career, Rosie held various roles at Eisai, MGI Pharma and PPD.

 

Rosie earned her B.S. in Biology with a minor in Chemistry from the University of Pittsburgh.

Session Details:

Chairperson’s opening remarks

2025-05-20, 8:30 AM

Session Details:

Chairperson’s closing remarks

2025-05-20, 5:45 PM

Session Details:

Chairperson’s opening remarks

2025-05-21, 8:50 AM

View In Agenda
Next speaker
Back
Carrie Lewis
Executive Director, Clinical Program Optimization, Endo Pharmaceuticals

Carrie Lewis has over 20 years of varied Clinical Research experience.  Carrie is currently an Executive Director, Clinical Program Optimization at Endo USA, Inc. where she oversees Clinical as well Business Operations, eTMF/inspectional readiness, and Training/Oversight.  Prior to Endo, Carrie garnered extensive knowledge in many roles while in academia, at large sponsors, generic sponsor, as well as a global CRO.  She has a Master’s Degree in Clinical Research Administration and has experience in multiple therapeutic areas.

Session Details:

CASE STUDY: Getting a new site up and running: challenges, opportunities and lessons learned

2025-05-20, 12:00 PM

View In Agenda
Next speaker
Back
Suzy Montanye
Site Relationship Manager, Endo Pharmaceuticals

Session Details:

CASE STUDY: Getting a new site up and running: challenges, opportunities and lessons learned

2025-05-20, 12:00 PM

View In Agenda
Next speaker
Back
Cole Eshbach
Sr. Clinical Trial Manager, Endo

Cole Eshbach is a clinical research professional with experience managing Phase 1-4 trials, driving innovation, and fostering collaboration.  With over six years dedicated to Endo projects, along with previous roles at Global CROs, have further enriched his skill set.  Before entering the clinical research industry, Cole conducted assessments for Autism (ADOS-II) in the greater Philadelphia area and completed behavioral consulting.

Next speaker
Back
Dr Nan Zhang
Senior Vice President, Central Lab, Biomarker and Biologics Services, Frontage Laboratories

Session Details:

Built different: how a BioA-rooted central lab delivers precision in a dynamic clinical landscape

2025-05-20, 2:30 PM

View In Agenda
Next speaker
Back
Amanda Murphy
Senior Director, Data Intelligence & Solutions,
GlobalData

Amanda Murphy is the Director of Product Management at GlobalData, a company that focuses on research, data analytics and consulting that provide actionable insight into the pharmaceutical and medical device sectors.  She has 10+ years of experience working in pharmaceutical data science and web platform development (including BioPharm Insight, Lead Sheet, and the Pharma Intelligence Center).  She has developed models and solutions to support Clinical Operations & Feasibility teams plan and optimize trials, including an e-feasibility questionnaire tool resulting in 4x faster response rates from sites.  Amanda also has many years of experience supporting business development at CROs through data-driven lead delivery and CRM integration solutions.

Session Details:

Innovative approaches to measure your performance and identify areas for improvement in supplier relationships

2025-05-20, 11:00 AM

Session Details:

The state of the biopharmaceutical industry in 2025

2025-05-21, 12:15 PM

View In Agenda
Next speaker
Back
Chris Riley
Ph.D, Senior Product Manager, H1 Clinical

Session Details:

Expanding the patient universe: transforming clinical trials through inclusive, data-driven design

2025-05-20, 2:30 PM

View In Agenda
Next speaker
Back
Melanie Goodwin
Director, Clinical Outsourcing, Immunocore

Session Details:

PANEL: Ensuring your FSP model is a success: what do you need to know?

2025-05-21, 9:00 AM

View In Agenda
Next speaker
Back
Linda Miller
Senior Clinical Operations Lead, Incyte

Session Details:

Marriage counseling: how two nurses from both the hospital and industry side see us resolving the site v sponsor chasm

2025-05-20, 2:00 PM

View In Agenda
Next speaker
Back
Todd Nicklas
Clinical Trial Manager, Incyte

Session Details:

Marriage counseling: how two nurses from both the hospital and industry side see us resolving the site v sponsor chasm

2025-05-20, 2:00 PM

View In Agenda
Next speaker
Back
Harsha K. Rajasimha
MS, Ph.D, Founder and Executive Chairman, Indo US Organization for Rare Diseases

Session Details:

PANEL: Navigating the outsourcing landscape for emerging therapy areas

2025-05-21, 2:15 PM

Session Details:

Medically underserved populations and the impact on rare disease clinical trials

2025-05-21, 9:00 AM

View In Agenda
Next speaker
Back
Russell Bland
Director, Clinical Outsourcing and Innovation, Jazz Pharmaceuticals

Session Details:

PANEL: Ensuring your FSP model is a success: what do you need to know?

2025-05-21, 9:00 AM

View In Agenda
Next speaker
Back
Mario D’Achille
Senior Director, GCDO Clinical Operations, Neuroscience Lead, Jazz Pharmaceuticals
Next speaker
Back
Ashlyn Jose
Director, Clinical Operations, Kyowa Kirin, Inc

Session Details:

PANEL: Innovation and technology in clinical trials: exploring emerging and upcoming trends

2025-05-20, 11:00 AM

View In Agenda
Next speaker
Back
Jessica Truscello
Senior Vice President, Clinical Operations, Lava Therapeutics
Next speaker
Back
Lauren Colfer
Former Vice President, Clinical Operations at Aceragen Pharmaceuticals

Lauren joins us with over 25 years of pharmaceutical development experience in both large and small pharmaceutical company settings.  Her career started as a clinical monitor with Covance which eventually led to oversight of clinical and medical affairs operations teams at Wyeth, Pfizer, Cephalon and Teva across multiple therapeutic areas.  Her biotech experience includes Head of Clinical Operations and Project Management at Recro Pharmaceuticals and, most recently, Head of Clinical Operations at Aceragen Pharmaceuticals (formerly Idera Pharmaceuticals).

Lauren holds a BS in Biology from the University of Scranton and an MBA in Biotechology and Health Industry Management from Pennsylvania State University.

Session Details:

PANEL: Handling clinical trial finances: tips for managing funding, investment and budgets

2025-05-20, 3:00 PM

View In Agenda
Next speaker
Back
Jamie Russo
Head of Product, AG Mednet

Session Details:

Leveraging technology for seamless collaboration

2025-05-21, 11:45 AM

View In Agenda
Next speaker
Back
Anka Ehrhardt
Director Cell-Based Assays / Analytical Research & Development, Merck

Dr. Ehrhardt is a biophysicist with a Ph.D. in human physiology. Throughout her career, she focused on driving biomedical research through efficient application of innovative technologies and strategies. She built and led successful teams in industry, including at Merck, where she headed a laboratory providing leading technologies for cell-based research from early discovery through manufacturing; and at BMS where Dr. Ehrhardt led and grew an international clinical assay team to robustly cover large scale registrational and translational clinical analysis generating clinical decision-driving data and mechanistic insights for immuno-oncology, cardiovascular, immunology, metabolic and rare disease studies. Before returning to Merck, Dr. Ehrhardt fulfilled one of her scientific aspirations at CHDI Foundation, designing and implementing successful clinical biomarker discovery and development strategies for Huntington’s disease. Currently, at Merck, Dr. Ehrhardt is providing strategic and technical leadership for the development and implementation of industry-leading and QC-friendly cell-based assays and models for potency determination that reflect the unique mechanisms of biologics products in clinical studies and beyond.

Next speaker
Back
Kristen Olszyk
Senior Director, Clinical Scientist, Neuraptive Therapeutics

Kristen Olszyk joined Neuraptive in March 2020 and is the Acting Head of Clinical Operations.  She brings with her 20 years in the pharmaceutical industry.  Kristen’s areas of expertise include data science, clinical development, clinical operations and regulatory affairs, and she has been involved with several successful regulatory submissions in multiple therapeutic areas.  Prior to joining Neuraptive, Kristen held positions at Wyeth Pharmaceuticals/Pfizer, Endo Pharmaceuticals and Paratek Pharmaceuticals.

 

Kristen earned her Bachelor of Science degree in Biochemistry from The Pennsylvania State University and her Master of Science degree in Quality Assurance and Regulatory Affairs from Temple University School of Pharmacy.

Session Details:

PANEL: Innovation and technology in clinical trials: exploring emerging and upcoming trends

2025-05-20, 11:00 AM

View In Agenda
Next speaker
Back
Ram Raju
Senior Vice President and Community Health Investment Officer, Northwell Health

Dr. Ram Raju has a distinguished career over 40 years as a healthcare provider, teacher, researcher and community organizer. In his role at Northwell Health, Dr. Raju set the strategic vision to improve population health by finding ways to meet the needs of its most vulnerable communities, by examining the existing programs aimed at improving the health system's response to the community's needs and working with local organizations to address them. Northwell Health is the largest healthcare provider in the state of New York, is a system with 23 hospitals and 830 outpatient facilities that sees 2 million people every year in the New York metro area and beyond.

Session Details:

PANEL: Diversity in clinical trials: how to ensure your clinical study has diverse representation

2025-05-20, 9:45 AM

Session Details:

PANEL: Innovation and technology in clinical trials: exploring emerging and upcoming trends

2025-05-20, 11:00 AM

View In Agenda
Next speaker
Back
Jim Mordaga
MBA, MA, Senior Director, Medical Platforms and Intelligence, Novartis

Session Details:

Innovative approaches to measure your performance and identify areas for improvement in supplier relationships

2025-05-20, 11:00 AM

View In Agenda
Next speaker
Back
Rick O’Hara
Director, R&D Business Operations, OncoC4

Session Details:

PANEL: Handling clinical trial finances: tips for managing funding, investment and budgets

2025-05-20, 3:00 PM

View In Agenda
Next speaker
Back
Priya Marreddy
Vice President, Clinical Operations, OnCusp Therapeutics

Session Details:

PANEL: Navigating the outsourcing landscape for emerging therapy areas

2025-05-21, 2:15 PM

View In Agenda
Next speaker
Back
Paresh Patel
Head Of Global Clinical Intelligence, Otsuka

Session Details:

PANEL: AI and machine learning in clinical trials: where are we in 2025?

2025-05-20, 2:00 PM

View In Agenda
Next speaker
Back
TJ Sharpe
Patient Advocate
Next speaker
Back
Albert A Siha
Director, Oncology Unit Management Office, Procurement and Supplier Relationship Manager, Pfizer

Session Details:

PANEL: Best practice in supplier relationship management: managing evolving needs to foster positive collaboration

2025-05-20, 12:00 PM

View In Agenda
Next speaker
Back
Eleanor Miller
Clinical Trial Liaison, PSI CRO

Eleanor Miller, Clinical Trial Liaison, is an oncology certified nurse with 17 years of oncology nursing experience at academic medical centers, including both inpatient and outpatient care, most recently leading an oncology nurse navigation program. Much of her career has been in direct collaboration with investigators and research teams to improve patient access to trials through increased awareness, patient education, and coordination of care.

 

At PSI, she uses this operational and clinical expertise to develop site specific recruitment strategies, tailored study tools and training. She can anticipate barriers to enrollment and resolve site needs with the project team. Eleanor is a strong collaborator and strategic thinker by identifying patterns, and bridging gaps between sites, clinical operations, project management, and sponsors.

Session Details:

Driving success: strategies for optimal site support

2025-05-21, 11:45 AM

View In Agenda
Next speaker
Back
PATRICK FLOODY
Executive Director, Global Clinical Trial Services, Regeneron Pharmaceuticals

Patrick has over 27 years’ experience in new drug development. He joined Regeneron in March 2020. His current role is the Head of the Global Clinical Trial Services group, responsible for global site management, central monitoring, study feasibility and site selection, study/site start up and eCOA and patient technology initiatives. Prior to this, Patrick spent 25 years at Pfizer, with most of his time spent in clinical program operations but also includes GCP Quality (level 1) and Analytics. Patrick has extensive international experience in drug development. He helped establish the Pfizer country office development teams in Latin America, India and other parts of Asia. Subsequently, Patrick spent 10 years in Pfizer’s Development Japan organization as Head of Japan Development Operations and Development Japan Portfolio & Project Management Groups. He was the recipient of the PGRD Achievement Award in 2007. Patrick is a former officer in the U.S. Army and is a veteran of the first Gulf War. He holds a bachelor’s degree in Biology from the University of Rhode Island and a Master of Business Administration from Temple University.

Next speaker
Back
John Seman
Chief Executive Officer, REVITALE Pharma

John Seman is the CEO and Founder of REVITALE Pharma.  He began his career working in Big Pharma - Johnson & Johnson and Bristol Myers Squibb - in sales, marketing and business development.  The second half of his career was spent as a serial entrepreneur having Founded a half dozen companies that provided either products or services for the pharmaceutical industry.  John earned his bachelor's and master's degrees from the Massachusetts College of Pharmacy.

Session Details:

PANEL: Best practice in supplier relationship management: managing evolving needs to foster positive collaboration

2025-05-20, 12:00 PM

Session Details:

CASE STUDY: Practical aspects of running a clinical trial when repurposing an existing drug

2025-05-20, 4:30 PM

View In Agenda
Next speaker
Back
Robert Besthof
Chief Operating Officer, RiboNova

Session Details:

PANEL: Optimizing remote data capture: new trends and technology in data acquisition

2025-05-21, 11:15 AM

View In Agenda
Next speaker
Back
Haifa Tyler
Executive Director, Head of Clinical Operations, RiboX Therapeutics
Next speaker
Back
Prasanna Rao
Chief Product and Innovation Officer, Saama

Session Details:

Smarter, faster, autonomous: the future of clinical data management with generative and agentic AI

2025-05-20, 9:15 AM

View In Agenda
Next speaker
Back
Jay Madan
Chief Financial Officer, SGN Nanopharma
Next speaker
Back
Mohan Bangalore
PhD, Director, Global R&D Procurement and Supplier Management, Organon

Session Details:

Evolving sourcing needs and models in clinical R&D

2025-05-20, 8:45 AM

Session Details:

PANEL: Navigating the outsourcing landscape for emerging therapy areas

2025-05-21, 2:15 PM

View In Agenda
Next speaker
Back
Patrick Ronan
Operating Partner, ArchiMed and Board of Directors, Symbio Research

Session Details:

Trump Administration effect on healthcare through the lens of a former regulator

2025-05-20, 12:30 PM

View In Agenda
Next speaker
Back
Bryan Fulop
Associate Director, Laboratory Services, Global R&D Procurement, Teva Pharmaceuticals
Next speaker
Back
Judyth Zahora
Senior Director, Global Quality Systems and Process Improvement, Agenus

Session Details:

PANEL: AI and machine learning in clinical trials: where are we in 2025?

2025-05-20, 2:00 PM

Session Details:

PANEL: Navigating the outsourcing landscape for emerging therapy areas

2025-05-21, 2:15 PM

Session Details:

PANEL: Preparing for an FDA inspection: common pitfalls and ensuring your study is ready for approval

2025-05-21, 10:00 AM

View In Agenda
Next speaker

Advisory Board

Select a member to learn more

Back
Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals

In her over 25 years of experience, Rosalie “Rosie” Filling has transformed R&D operations in every company she has worked for, developing clear-cut strategies to help advance clinical trials with high-quality operational execution and scientific excellence.

 

Rosie is the Vice President, Senior Global Head R&D Operations Endo International plc. She is part of the global R&D leadership team and is charged with the coordination and implementation of clinical development strategies for the company’s research and development. She provides strategic direction and oversight of the R&D Operations team, which includes clinical operations, data management, biostatistics, medical writing, clinical supplies, trial master file/inspection readiness and business operations. This integrated team handles the execution of all aspects related to Endo’s clinical trials. Endo has active research and development programs in men’s health, orthopedics, and endocrinology. Beyond these therapeutic areas, the company also has focused development in the areas of sterile injectables and complex generic products.

 

Rosie’s main focus at all times is on the end users—the patients. Bringing new and, at times, life-saving medications to patients drives Rosie’s sense of purpose.

 

Rosie joined Endo from Lupin Pharmaceuticals in Blue Bell, PA where she was Senior Director, Head of Clinical Operations, and built the clinical operations organization to support the US and Global R&D Organization. Prior to Lupin, Rosie spent nearly five years at Teva in Frazer, PA where she was the US site head of Clinical Operations and was responsible for the successful delivery of Inhalation, Women’s Health, and Cardiovascular clinical trials. Earlier in her career, Rosie held various roles at Eisai, MGI Pharma and PPD.

 

Rosie earned her B.S. in Biology with a minor in Chemistry from the University of Pittsburgh.

Session Details:

Chairperson’s opening remarks

2025-05-20, 8:30 AM

Session Details:

Chairperson’s closing remarks

2025-05-20, 5:45 PM

Session Details:

Chairperson’s opening remarks

2025-05-21, 8:50 AM

View In Agenda
Next
Back
Kathleen Cohen
Vice President, Clinical Development, Marinus Pharmaceuticals

Kathleen Frenia Cohen is Vice President and Head of Clinical Development Operations at Marinus Pharmaceuticals.  Prior to joining Marinus, she spent 20+ years at PRA Health Sciences in a variety of project management and operational oversite roles. Kathleen graduated from the University of the Science in Philadelphia with a PharmD and completed a post-doctoral fellowship in Pharmacoeconomics and Outcomes Research from Rutgers College of Pharmacy. Kathleen resides in Media, PA.

Session Details:

PANEL: Best practice in supplier relationship management: managing evolving needs to foster positive collaboration

2025-05-20, 12:00 PM

Session Details:

PANEL: Diversity in clinical trials: how to ensure your clinical study has diverse representation

2025-05-20, 9:45 AM

View In Agenda
Next
Back
THOMAS M TREMBLAY
Vice President Of Clinical Development, Trefoil Therapeutics, Inc

Thomas is a registered nurse with both clinical and over 30 years pharmaceutical development experience. His pharmaceutical development experience includes clinical operations, clinical science, clinical development, drug safety and quality. He is currently Vice President of Clinical Development at Trefoil Therapeutics and adjunct faculty at San Francisco State University.

Next
Back
Behtash Bahador
Director, Health Literacy, CISCRP

Behtash Bahador is the Director of Health Literacy at the non-profit organization CISCRP, and holds a Master of Science in Health Communication from the Tufts University School of Medicine. Since 2014, he has collaborated with a range of stakeholder groups to establish and implement patient- and public-centric initiatives across the life-cycle of drug and treatment development. This has included supporting the development of regulatory and cross-disciplinary best practice guidelines, operationalizing key elements of evidence-based public health programing into research engagement activities, and always keeping the needs of patients, participants and the public at the forefront of his work.

Next
Back
Bao Dinh
Global Development Business Operation, Takeda

With over 15 years of experience in Clinical Data Management, Bao leads business strategy and vendor operations for Takeda’s Clinical Data Management, Clinical Data Engineering, and Clinical Data Standards groups, driving organizational growth, managing global FSP partnerships, and enhancing cross-functional collaboration. As a member of the 2024–2025 OCT Advisory Board, Bao brings expertise in clinical outsourcing, strategic vendor partnerships, and RFP process optimization, providing a fresh vision for the organization.

Beyond professional achievements, Bao is dedicated to fostering collaboration and investing in the local community. As a partner of The Town FC and a Silicon Valley angel investor, Bao champions ventures that advance sustainable growth, youth enrichment, and innovation in technology.’

Next

Plan Your Visit

Venue

Valley Forge Casino Resort

1160 1st Ave, King of Prussia, PA 19406, United States

Accommodation

Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group..

Sponsors

Select a sponsor to learn more

Featured Sponsor

Session Sponsors

Technology Showcase Sponsor

Exhibitors

Co-Sponsor

Why partner?

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 450+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Resources

       
       
   

Media Centre

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Nick McCudden

Head of OCT Events

SPEAKING OPPORTUNITIES

Louisa Manning

Programme Director

+44 (0)20 766 10552

MARKETING ENQUIRIES

Moona Popal

Senior Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

Sponsorship Enquiries

To enquire about sponsorship opportunities for the conference, please contact:

 

Nick McCudden

Head of OCT Events


 

Speaker Enquiries

To enquire about sponsorship opportunities for the conference, please contact:

 

Louisa Manning

Programme Director


+44 (0)20 766 10552